Return to: Pediatrics : Medical School : Academic Health Center : myU : U of M Home
Gold University of Minnesota M. Skip to main content. Link to University of Minnesota homepage
One Stop | Directories | Search U of M 
Division of Endocrinology, Department of Pediatrics
Whats Inside
For Patients and Families

Faculty Research

Education

Faculty and Staff

Research Patient Opportunities

Contact Us

For Healthcare Providers

 

Peds Endocrinology Home


University Pediatrics Foundation - Make a Gift

Viking Children's Fund

Children's Cancer Research Fund

Department of Pediatrics > Endocrinology > Research Patient Opportunities > Thymoglobulin (ATG) to Preserve Beta Cell Function in New Onset Type 1 Diabetes

Printer-friendly version   Mail this page to a friend

Thymoglobulin (ATG) to Preserve Beta Cell Function in New Onset Type 1 Diabetes


The purpose of this study is to prevent the progression of type 1 diabetes in those with new onset type 1 diabetes (less than 6 weeks after diagnosis). Age is 18-35. Patients are randomly assigned to receive infusions of antithymocyte globulin or a placebo. There is no cost for study participation.

Contact Person: Carrie Gibson, RN, BSN
Phone: 612-624-5958
Toll Free: 800-688-5252 ext. 45958
Email: gibso002@umn.edu

Feedback | Notice of Privacy Practices


 
©2002-2008 Regents of the University of Minnesota. All rights reserved. Trouble seeing the text? | Contact U of M | Privacy
The University of Minnesota is an equal opportunity educator and employer.
  Last modified on Monday Jun 02, 2008